ETON
Eton Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.83 / 10
Outperform
Analyst consensus is overwhelmingly bullish: five Strong Buy ratings, with Craig‑Hallum showing a 66.7% historical win rate. Fund‑flow metrics are excellent, displaying positive inflows across all investor sizes and an 8.11/10 score, supporting strong buying pressure.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-20
InstitutionCraig-Hallum
Times predicted3
Historical Win Rate66.7%
What is the analyst consensus for ETON?
- ETON holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.83/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
